HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

IFF Will Limit Itself To “Bolt-On” Acquisitions, Skeptical Of Givaudan/Quest

This article was originally published in The Rose Sheet

Executive Summary

Givaudan's acquisition of Quest International in March - and the hulking size of the combined entity - may prove a handicap within the competitive fragrance and specialty molecule sector, International Flavors and Fragrances CFO Doug J. Wetmore suggested Sept. 5

You may also be interested in...



Sales & Earnings In Brief

Procter & Gamble: Double-digit growth of P&G's prestige fragrances business was central to fourth-quarter and fiscal 2007 growth, according to an Aug. 3 release. Full-year net beauty sales increased 9% to $23.0 billion, firm says, attributing growth to Boss Selection and Boss Femme fragrance initiatives and the addition of Dolce & Gabbana's The One through a July 2006 licensing deal (1"The Rose Sheet" Dec. 19, 2005, In Brief). High single-digit skin-care growth was driven by Olay Definity and Regenerist, while hair-care sales increased by mid-single-digits on strong performances from Pantene, Head & Shoulders and Herbal Essences, P&G says. Q4 beauty sales totaled $5.9 bil., up 8%, with significant contributions coming from Escada and Lacoste within firm's prestige fragrances segment, as well as Dolce & Gabbana. Overall, company sales for the year rose 12% to $76.5 bil. Fourth-quarter revenue was up 8% to $19.3 bil. Double-digit increases in Blades & Razors and Health Care divisions were driven by sales of Gillette Fusion and Crest Pro-Health; Fiscal 2008 sales are expected to grow 5% to 7%...

Givaudan Predicts Quest Buy Will Prompt Rivals To Move Up In Weight Class

Givaudan expects its March 2 acquisition of Quest International - which the fragrance and flavor developer claims will make it 60 percent larger than its closest competitor - to compel similar movement throughout the industry

FTC Notifies ReJuvenation ‘Anti-Aging’ Pill Purchasers To Expect (Or Request) Mailed Refunds

The sellers of the anti-aging “cure-all” reached an agreement with the FTC in February that prohibits them from making false and unsubstantiated health claims and requires them to pay $660,000 in total to the Commission. Refund checks now are being issued to more than 1,300 defrauded consumers.

UsernamePublicRestriction

Register

LL055695

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel